ixekizumab
eli lilly
['ixekizumab', 'achieve,(-u achieve),(-u-achieve),(-uachieve)', 'axspa']
good news for patients who require short interruptions in biologic therapy!
majority of axspa patients (82%) who restarted ixekizumab after withdrawing, achieved low disease activity and 68% eventually had inactive disease. #abs0427 #acr22
Rheumatologist. Amateur chef. YNWA. Views and opinions are my own.